Medical Developments International | MVP - Interest Expense On Debt

Stock Price
0.48
Daily Change
-0.01 -1.03%
Monthly
-14.29%
Yearly
-27.82%
Q1 Forecast
0.46

Medical Developments International reported AUD18K in Interest Expense on Debt for its fiscal semester ending in June of 2025.





Interest Expense On Debt Change Date
Alaunos Therapeutics USD 0 0 Dec/2023
Avita Medical AUD 1.25M 100K Jun/2025
Clinuvel Pharmaceuticals AUD 2.43M 414.48K Jun/2024
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Genetic Signatures AUD 18K 17K Jun/2024
Ionis Pharmaceuticals USD 18M 1000K Sep/2025
Medical Developments International AUD 18K 3K Jun/2025
Neuren Pharmaceuticals AUD 0 0 Jun/2024
Organon & Co USD 128M 3M Sep/2025
Paradigm Biopharmaceuticals AUD 1000 3K Jun/2025
PYC Therapeutics AUD 17K 11K Jun/2025
Tectonic Therapeutic USD 277M 276.98M Sep/2025
Telix Pharmaceuticals AUD 18.84M 15.45M Jun/2025
Viatris USD 119.6M 3M Sep/2025
Xeris Pharmaceuticals USD 7.27M 92K Sep/2025